mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

November 25, 2026

Conditions
Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy VolunteersSARS CoV-2
Interventions
BIOLOGICAL

COMIRNATY®

COVID-19 Vaccine, mRNA suspension

Trial Locations (1)

30030

Hope Clinic of the Emory Vaccine Center Division of Infectious Diseases, Department of Medicine, School of Medicine, Decatur

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Emory University

OTHER

lead

PharmaJet, Inc.

INDUSTRY

NCT06919796 - mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes | Biotech Hunter | Biotech Hunter